• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORASURE TECHNOLOGIES INC INTERCEPT; INTERCEPT ORAL FLUID DRUG TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORASURE TECHNOLOGIES INC INTERCEPT; INTERCEPT ORAL FLUID DRUG TEST Back to Search Results
Model Number 503-0509
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Patient Problem/Medical Problem (2688)
Event Type  Injury  
Event Description
It was reported on (b)(6) 2019 to orasure technologies, inc.That a customer had an allergic reaction to our intercept oral drug screen test.The employee was currently in the er with a swollen throat/tongue.The customer was provided the safety statement for the intercept oral swab device to determine if a component may caused the allergic reaction in the customer.The customer returned to work on (b)(6) 2019 but reported to still be shaking and swollen.The customer was still having symptoms as of (b)(6) 2019 and had made an appointment with a specialist for allergy testing to be completed.
 
Event Description
It was reported on (b)(6) 2019 to orasure technologies, inc.That a customer had an allergice reaction to our intercept oral drug screen test.The employee was currently in the er with a swollen throat/tongue.The customer was provided the safety statement for the intercept oral swab device to determine if a component may caused the allergic reaction in the customer.The cusotmer returned to work on (b)(6) 2019 but reported to still be shaking and swollen.The cusotmer was still having symptoms as of (b)(6) 2019 and had made an appointment with a specialist for allergy testing to be completed.
 
Manufacturer Narrative
It was reported on (b)(6) 2019 to oti that a customer had an allergic reaction to the intercept oral device.The employee was currently in the er with a swollen throat and tongue.The customer was provided the safety statement for the intercept oral swab device to try and determine a root cause of the allergic reaction the customer experienced.The customer returned to work on (b)(6) 2019 but reported to still be shaking and swollen.The customer was still having symptoms as of (b)(6) 2019 and had made an apointment with an allergy specialist for testing to be completed.The last patient update was received on (b)(6) 2019.The customer is currently undergoing allergy testing now to figure out what the reaction was caused by.A blood test for food/medicine ingested has already been completed with nothing coming back that she was allergic to.A second skin test was scheduled to be performed but there was no information as to whether this would conclude the skin testing or when results would be received.The customer was informed at this time that without further information this complaint would be closed.The customer reported that she would let us know if any further information was presented.Since no information was available on any possible allergies to any of the chemical components of the device, this will be resolved as unconfirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERCEPT
Type of Device
INTERCEPT ORAL FLUID DRUG TEST
Manufacturer (Section D)
ORASURE TECHNOLOGIES INC
220 east first street
bethlehem PA 18015
MDR Report Key8391484
MDR Text Key137865960
Report Number3004142665-2019-00002
Device Sequence Number1
Product Code PJD
Combination Product (y/n)N
PMA/PMN Number
K011057
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type user facility
Remedial Action Notification
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/30/2020
Device Model Number503-0509
Device Lot Number0006667361
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date02/13/2019
Initial Date Manufacturer Received 02/13/2019
Initial Date FDA Received03/05/2019
Supplement Dates Manufacturer Received02/13/2019
Supplement Dates FDA Received04/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-